OPTHF
Optimi Health Corp.
No data for this timeframe.
Vol
SEC Reports4
Recent Activity
May 26, 2026
SEC
Optimi Health Corp. announced completion of a production run of naturally derived psilocybin extract measuring approxima
6-K — Impact 4/10
May 19, 2026
SEC
Optimi Health Corp., a Canadian GMP-compliant psychedelic pharmaceutical manufacturer, filed Amendment No. 8 (F-1/A) to
F-1/A — Impact 5/10
Apr 23, 2026
SEC
Optimi Health Corp., a Canadian psychedelic pharmaceutical company, is conducting its U.S. IPO by registering 2.5 millio
F-1/A — Impact 5/10
Latest Reports
NEUTRAL
6-K
4/10
Optimi Health Corp. announced completion of a production run of naturally derived psilocybin extract measuring approxima
May 26, 2026
NEUTRAL
F-1/A
5/10
Optimi Health Corp., a Canadian GMP-compliant psychedelic pharmaceutical manufacturer, filed Amendment No. 8 (F-1/A) to
May 19, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
4 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 4 neutral. Avg impact: 4.8/10.
NEUTRAL
6-K
4/10
Optimi Health Corp. announced completion of a production run of naturally derived psilocybin extract
May 26, 2026
NEUTRAL
F-1/A
5/10
Optimi Health Corp., a Canadian GMP-compliant psychedelic pharmaceutical manufacturer, filed Amendme
May 19, 2026
NEUTRAL
F-1/A
5/10
Optimi Health Corp., a Canadian psychedelic pharmaceutical company, is conducting its U.S. IPO by re
Apr 23, 2026
NEUTRAL
F-1/A
5/10
Optimi Health Corp., a Canadian psychedelic pharmaceutical company, is conducting its U.S. IPO by re
Apr 21, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.